GROWTH BUYOUT & VENTURE CAPITAL

Engaged Partnership - A long-term view.
The essentials for transformative growth in life sciences.

 


Latest Investment

Corium is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage the company's

News

KemPharm logo

2019-09-04

KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital